Niki BioSolutions, Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities
Niki BioSolutions, Inc. (NIKI) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of -$712.92 thousand for the 6-month period ending 2021-06-30, per its 6-K filed 2021-09-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2021-09-15
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|
| 2021-06-30 | -$712.92K 6-K · filed 2021-09-15 | |
| 2020-12-31 | -$1.48M 20-F · filed 2021-04-19 | |
| 2020-06-30 | -$584.09K 6-K · filed 2021-09-15 | |
| 2019-12-31 | -$1.61M 20-F · filed 2021-04-19 | |
| 2019-06-30 | -$593.81K 6-K · filed 2020-09-02 |